Pharmaceutical Investing ARCA biopharma Submits Patent Application to US Patent and Trademark Office for Atrial Fibrillation
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation
